Xarelto® Litigation Update - Reyes Browne Reilley

MARCH 25, 2019 – Bayer and Johnson & Johnson have agreed to settle roughly 25,000 lawsuits that resulted from their blood thinner medicine, Xarelto®. Both companies will pay a sum of $775 million, split evenly between the two companies.

Both companies deny liability, and still stand behind their product albeit thousands of patients suffering from irreversible internal bleeding. Instead, they have decided to settle because of the extensive time and resources devoted to litigation.

The most serious potential injury caused by Xarelto® is internal bleeding. Currently, there is no known potential cure to reverse the type of blood loss caused by Xarelto®, other than possibly emergency dialysis.

Serious Side Effects Include:

  • Stroke
  • Intracranial hemorrhage
  • Epidural hemorrhage
  • Gastrointestinal hemorrhage
  • Retinal hemorrhage
  • Adrenal hemorrhage
  • Death
Previous Post Next Post